ALNYLAM PHARMACEUTICALS, INC.;ALNYLAM PHARMACEUTICALS; INC.;ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
发明人:
BETTENCOURT, BRIAN,FITZGERALD, KEVIN,QUERBES, WILLIAM,DESNICK, ROBERT J.,YASUDA, MAKIKO
申请号：
CA2925357
公开号：
CA2925357A1
申请日:
2014.10.03
申请国别(地区):
CA
年份:
2015
代理人:
摘要：
The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the ALAS1 gene, and methods of using such dsRNA compositions to alter (e.g., inhibit) expression of ALAS1.
